The House and Senate have approved the following health policy bills, which now await the President’s signature: H.R. 2923, the Combat Methamphetamine Enhancement Act; S. 1674, the Improving Access to Clinical Trials Act (to provide for an exclusion under the Supplemental Security Income program and Medicaid for compensation of individuals who participate in clinical trials for rare diseases or conditions); and S. 3751, the Stem Cell Therapeutic and Research Reauthorization Act. In addition, the House recently approved the following bills, which still await Senate action: H.R. 3470, Nationally Enhancing the Wellbeing of Babies through Outreach and Research Now (NEWBORN) Act (which would authorize funding for infant mortality pilot programs in areas with high rates of infant mortality); H.R. 5809, the Safe Drug Disposal Act (which would provide for takeback disposal of controlled substances in certain instances); H.R. 5756, the Training and Research for Autism Improvements Nationwide Act; H.R. 3199, the Emergency Medic Transition Act (to provide grants to state emergency medical service departments to provide expedited training of veterans with prior medical training); H.R. 1745, the Family Health Care Accessibility Act (to provide liability protections for volunteer practitioners at health centers); H.R. 5710, the National All Schedules Prescription Electronic Reporting Reauthorization Act; H.R. 6012, to direct the HHS Secretary to review utilization of diabetes screening benefits and establish a related outreach program; H.R. 1362, the National MS and Parkinson’s Disease Registries Act; H.R. 1995, the Diabetes in Minority Populations Evaluation Act; H.R. 5986, the Neglected Infections of Impoverished Americans Act; H.R. 758, the Pediatric Research Consortia Establishment Act; H.R. 5354, the Gestational Diabetes Act; H.R. 1347, the Concussion Treatment and Care Tools Act; H.R. 2408, the Scleroderma Research and Awareness Act; H.R. 2818, the Methamphetamine Education, Treatment, and Hope Act; H.R. 1032, the Heart Disease Education, Analysis Research, and Treatment for Women Act; H.R. 1230, the Acquired Bone Marrow Failure Disease Research and Treatment Act; H.R. 2941, to reauthorize and enhance Johanna’s Law to increase public awareness and knowledge with respect to gynecologic cancers; H.R. 5462, the Birth Defects Prevention, Risk Reduction, and Awareness Act; and H.R. 1210, the Arthritis Prevention, Control, and Cure Act. Note that Congress has adjourned until November 15, 2010 (after the mid-term elections).